FORTREA’S AI INNOVATION STUDIO REVOLUTIONISES CLINICAL TRIALS EXECUTION

KUALA LUMPUR, June 28 (Bernama) -- Fortrea, a global contract research organisation (CRO), has launched its artificial intelligence (AI) Innovation Studio, signalling a strategic investment in reshaping the execution of clinical trials today and into the future.

According to Fortrea in a statement, the studio will develop and deploy AI and machine learning (ML) technologies to drive speed, agility, quality and enhanced patient safety in the clinical research process by equipping and empowering people to focus on the critical human element of clinical trials.

“Fortrea’s AI Innovation Studio will enable enhanced technological capabilities that will allow AI-enabled systems to perform cutting-edge processes, such as trial simulations, predictive analytics and pattern recognition, as well as repetitive, administrative, ‘machine-friendly tasks’,” said Fortrea Chief Information Officer, Alejandro Martinez Galindo.

bootstrap slideshow

Fortrea’s AI Innovation Studio aims to partner across Fortrea and with its customers to provide technology solutions for bespoke site and sponsor innovation strategies; develop net new, greenfield technology innovations; and support existing infrastructure and operations with enhanced technology.

Technologies under development in the studio include smartphone-enabled data collection; specialised large language models for text comprehension and generation; symbolic AI with real-valued logic, namely building decision logic using real-world scenarios and data; mixed reality and augmented intelligence; advanced data mining and predictive analytics; as well as digital twinning.

Strategic application of these technologies is expected to result in meaningful advancements in patient recruitment and retention, protocol creation/optimisation, risk-based quality monitoring and overall delivery speed and quality.

bootstrap slideshow

These technologies can also deliver an improved patient experience and greater productivity for Fortrea customers, sites and employees.

Developments from the AI Innovation Studio will be critical to Fortrea’s clinical technology platform, which is being designed to integrate clinical trial technology into a consumer-grade, location-agnostic, omni-channel, persona-based experience accessible through a single screen.

Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigour, exceptional insights and a strong investigator site network, with a team working in more than 90 countries to deliver focused and agile solutions to customers globally.

-- BERNAMA